Dean of Engineering
Vanderbilt University, United States
Dr. Krishnendu (Krish) Roy received his B. Tech. from the Indian Institute of Technology (IIT), Kharagpur, his M.S. from Boston University, and his Ph.D. in Biomedical Engineering from Johns Hopkins University. After two years in industry, Dr. Roy joined the Biomedical Engineering Faculty at The University of Texas at Austin in 2002, eventually becoming Professor and Fellow of the Cockrell Chair in Engineering Excellence. In 2013 he moved to Georgia Tech, where he was most recently a Regents Professor and the Robert A. Milton Endowed Chair in Biomedical Engineering. He also served as Director of three centers—the NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT), The Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M), and the Center for ImmunoEngineering. In August 2023, Dr. Roy joined Vanderbilt University as the Bruce and Bridgitt Evans Dean of Engineering and a University Distinguished Professor in Biomedical Engineering, and Pathology, Microbiology, and Immunology, with a secondary appointment in Chemical and Biomolecular Engineering.
In recognition of his seminal contributions, Dr. Roy has been elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE), the Biomedical Engineering Society (BMES), and the Controlled Release Society (CRS). He has received numerous awards and honors, including the Clemson Award for Basic Research from the Society for Biomaterials, the Industry Growth Award from Georgia Bio, Young Investigator Awards from the Controlled Release Society (CRS) and The Society for Biomaterials (SFB), the NSF CAREER award, etc. He has also received the Best Teacher Award from the Biomedical Engineering Students at UT-Austin and the Best Advisor Award from Bioengineering students at Georgia Tech. Dr. Roy serves on the Editorial Boards of the Journal of Controlled Release, the Journal of Immunology and Regenerative Medicine, and the Journal of Advanced Biomanufacturing and Bioprocessing. He also serves as a board member of the Standards Coordinating Body for Regenerative Medicine and several other academic and industry advisory boards. Starting in August 2023, he co-chairs the Forum on Regenerative Medicine of the National Academies of Science, Engineering, and Medicine (NASEM).
Disclosure information not submitted.
Poster CC15 - Engineering Immune Dysregulation in Acute Respiratory Distress Syndrome
Thursday, October 24, 2024
2:45 PM - 3:45 PM EST
Engineering Mucosal and systemic immune responses to severe influenza in human lung on chip
Friday, October 25, 2024
8:45 AM - 9:00 AM EST
Friday, October 25, 2024
3:30 PM - 4:30 PM EST
Friday, October 25, 2024
3:30 PM - 4:30 PM EST